Kya aapko bhi mil sakta hai ₹43,200 ka fayda? Jaane Q-Line Biotech ke IPO ke Gray Market Premium ke baare mein sab kuch
मुख्य बातें
- •Q-Line Biotech ka IPO 102 guna subscribe hua hai.
- •Company ne is IPO se lagbhag ₹214.48 crore ki poori raqam jama ki hai.
- •Gray Market Premium ₹108 hai, jisse investors ko ₹43,200 ka fayda milne ki ummeed hai.
- •Listing 29 May ko hone wali hai, jiske baad dekha jaayega ki bazar ka asli rukh kya hai.
Agar aapne haal hi mein aaye Q-Line Biotech ke IPO mein daav lagaya hai, toh aapki jholi khushiyon se bhar sakti hai—khaas kar agar aap Gray Market ke aankdon ko dekhenge. Company ke share ka upper price band ₹343 rakha gaya hai, lekin Gray Market Premium (GMP) ke taazah aankde bata rahe hain ki investors ko ek hi jhatke mein ₹43,200 tak ka tagda munafa ho sakta hai.
Yeh IPO itna hit raha ki isko 102 guna se zyada subscribe kiya gaya. Ab sabki nigahain 29 May ko hone wali listing par tik gayi hain. 102 guna bumper subscription ke kya hain matlab? Q-Line Biotech ka IPO khulne ke saath hi retail investors se lekar bade institutions tak ki pehli pasand ban gaya. Teen dinon tak chale is issue ko bazar se ummeed se kahin zyada behtareen response mila.